Combination therapy with a molecular target drug and iron chelator for the treatment of intractable hepatocellular carcinoma
Not Applicable
- Conditions
- advanced hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000013461
- Lead Sponsor
- Department of Gastroenterology, Okayama University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
active double cancers severe complications contraindication of the test drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety and compliance
- Secondary Outcome Measures
Name Time Method antitumor effect time to tumor progression overall survival effect to liver function and iron level